Program in neuroendocrine and carcinoid tumors

About the Neuroendocrine and Carcinoid Tumors Program At the Neuroendocrine and Carcinoid Tumors Program at Dana-Farber Brigham Cancer Center, our goal is to improve the lives of people with neuroendocrine tumors by offering patients a comprehensive range of services based on specialized treatments and innovative research. We offer an approach to treatment that includes: A team of oncologists specializing in neuroendocrine tumors. A multidisciplinary approach to care based on each patient's unique situation.

Highly advanced diagnostic procedures. Complex surgical procedures. Interventional radiology techniques, including embolization. Access to leading-edge clinical trials. Pathologic and molecular testing of tumor specimens. Genetic testing and counseling for families with a cancer history. Easy access and timely appointments. Innovative approach Investigators in the Neuroendocrine and Carcinoid Tumors Program have a proven track record of discovering new and promising treatment options.

Compassionate care At Dana-Farber Brigham Cancer Center, we view every patient as an individual, with unique needs and expectations. Information and Resources Becoming a Patient As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.

How Our Gastrointestinal Cancer Patients Rate Dana-Farber Take a look at our patient satisfaction survey results for our patients treated for gastrointestinal cancers. Support Services and Amenities We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.

Clancy's clinical focus is the treatment of gastrointestinal malignancies, specifically pancreatic, biliary, and liver tumors. In addition, Clancy has a specific clinical and research interest in neuroendocrine tumors. A high-volume clinical surgical oncologist, Clancy has expertise in the surgical management of primary small intestinal and pancreatic neuroendocrine tumors and resection of neuroendocrine tumor liver metastases.

Clancy has been a leader in the development and adoption of minimally-invasive treatment techniques, including robotic pancreatectomy. She completed her residency and fellowship training at Rhode Island Hospital in See the complete list of our gastrointestinal cancer specialists.

Read disclaimer about translations Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions.

You may request a live medical interpreter for a discussion about your care. Neuroendocrine and Carcinoid Tumors Program. Although most neuroendocrine tumors grow more slowly than many other cancers, some e.

Some neuroendocrine tumors are named by the hormones that they produce, such as gastrinoma gastrin , insulinoma insulin , glucagonoma glucagon , VIPoma VIP and carcinoid serotonin. Adrenal pheochromocytoma, paraganglioma and medullary carcinoma of the thyroid are names of other rare neuroendocrine tumors. The Carcinoid and Neuroendocrine Tumor Program provides comprehensive treatment for all types of neuroendocrine tumors.

Wolin, MD medical oncology , works closely with referring physicians to coordinate management, typically remaining in close touch by letter and phone. For new patient referrals, please call or send a message to our team. Call us or send a message to the Carcinoid and Neuroendocrine Tumor Program team.